Atypical pathogens of pneumonia acquired in ambulant persons;Atypische Erreger der ambulant erworbenen Pneumonie

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 10, 2004, Pages 503-508

  Tuschy, P ^a   Lorenz, J ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Klinikum Ludenscheid   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINOPENICILLANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; KETOLIDE; MACROLIDE; MINOCYCLINE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STEROID; TELITHROMYCIN; TETRACYCLINE DERIVATIVE;

CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COXIELLA BURNETII; HUMAN; LEGIONELLA PNEUMOPHILA; MYCOPLASMA PNEUMONIAE; NONHUMAN; OUTPATIENT CARE; PNEUMONIA; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEGIONNAIRES' DISEASE; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; Q FEVER; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT OUTCOME;

EID: 1542357600     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-820539     Document Type: Review

References (37)

1. Almirall J, Bolibar I, Vidal J et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15: 757-763
2. Block S, Hedrick J, Hammerschlag MR et al. Mycoplasma pneumoniae and Chlamydophila pneumoniae in pedriatic community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate. Pediatr Infect Dis J 1995; 14: 471-477
3. Braveny I, Maschmeyer G. Infektionskrankheiten: Diagnostik Klinik Therapie. 1. Auflage (Hrsg). medco-Verlag, ISBN 3000100210.2002
4. Burkhardt O, Straube E, Welte T. Klinisches Bild, Diagnostik und Therapie der Chlamydien-Pneumonie. Pneumologie 2003; 57: 449-458
5. Dowell SF, Peeling RW, Boman J et al. Standardizing Chlamydophila pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). CID 2001; 33: 492-503
6. Ewig S, Tuschy P, Fätkenheuer G. Diagnostik und Therapie der Legionellen-Pneumonie. Pneumologie 2002; 56: 695-703
7. Feikin DR, Moroney JF, Talkington DF et al. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at federal service training academy: new implications from an old scenario. Clin Infect Dis 1999; 29: 1545-1550
8. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. JAC 2002; 50: 25-37(Suppl S1
9. Hammerschlag MR. Mycoplasma pneumoniae infections. Curr Opin Infect Dis 2001; 14: 181-186
10. Hellenbrand W, Breuer T, Petersen L. Changing epidemiology of Q-fever in Germany, 1947 - 1999. Emerging Infect Dis 2001; 7: 789-796
11. Hellmeyer L, Schmitz-Ziegler G, Slenczka W, Schmidt S. Q-Fieber in der Schwangerschaft: Therapie und Handling des Krankheitsbildes anhand eines Fallberichtes. Z Geburtsh Neonatol 2002; 206: 193-198
12. Hindiyeh M, Carroll KC. Laboratory diagnosis of atypical pneumonia. Sem Respir Infect 2000; 15: 101-113
13. Hof H, Müller RL, Dörries R. Mikrobiologie. 1. Auflage (Hrsg). Thieme, ISBN 3131253118.2000: 401-403
14. Hof H, Müller RL, Dörries R. Mikrobiologie. 1. Auflage (Hrsg). Thieme, ISBN 3131253118.2000: 446-449
15. Hoffmann - Kamps. SARS-Reference 07-2003, Flying Publisher. www.SARSreference.com.
16. Huchon G, Woodhead M. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 1998; 11: 986-991
17. Kauppinen MT, Saikku P, Kujala P et al. Clinical picture of community-acquired Chlamydophila pneumoniae pneumonia requiring hospital treatment: a comparison between Chlamydophilal and pneumococcal pneumonia. Thorax 1996; 51: 185-189
18. Leigh MW, Clyde WA. Chlamydophilal and mycoplasmal pneumonias. Semin Respir Infect 1987; 2: 152-158
19. Lieberman D, Ben Yaakov M, Lazarovich Z et al. Chlamydophila pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infection 1996; 24: 109-114
20. Lieberman D, Lieberman D, Boldur I et al. Q-fever in the Negev Region of Isreal: a review of 20 patients hospitalised over a period of one year. J Infect 1995; 30: 135-140
21. Lieberman D, Schlaeffer F, Boldur I et al. Multiple pathogens in adult patients community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51: 179-184
22. Lim WS. Macfarlane JT, Boswell TC et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: 296-301
23. Marston BJ, Plouffe JF, File TM et al. Incidence of community-acquired pneumonia requiring hospitalisation. Arch Intern Med 1997; 157: 1709-1718
24. Marrie TJ. Coxiella burnetiii pneumonia. Eur Respir J 2003; 21: 713-719
25. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12: 518-533
26. Mundy PM, Oldach D, Amcaerler PG et al. Implications of macrolide treatment in community-acquired pneumonia. Chest 1998; 113: 1201-1206
27. Murray HW, Masur H, Senterfit HB, Roberts RB. The protean manifestations of Mycoplasma pneumoniae infections in adults. Am J Med 1975; 58: 229-242
28. Osler W. Lobar pneumonia. Pentland, Edinburgh & London, In: Young J (ed) The Principles and Practice of Medicine. 1901: 125-129
29. Pschyrembel. Klinisches Wörterbuch. 258. Auflage (Hrsg). Verlag de Gruyter, 1998
30. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch für 2002; 1. Auflage (Hrsg). Berlin, www.rki.de. 2003: 123-126
31. Ruiz-Gonzalez A, Falguera M, Nogues A, Rubio-Caballero M. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med 1999; 106: 385-390
32. Schaberg T, Ewig S. Pneumonien. 1. Auflage (Hrsg). Thieme, ISBN 3131058315. 2001: 46ff
33. Schaberg T, Dahlhoff K, Ewig S, Lorenz J, Wilkens H. DGP: Empfehlungen zur Therapie der ambulant erworbenen Pneumonie. Pneumologie 1998; 52: 450-462
34. Sopena N, Sabrià M, Pedro-Botet ML et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis 1999; 18: 852-858
35. WHO.-Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003, www.who.org,
36. www.protekt.org,
37. www.who.int/csr/sars/casedefinition/en/.